Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$27,000.00

Comprehensive characterization of neuroimmune profiles along the gastrointestinal tract of patients with Irritable Bowel Syndrome

EF 2024-25

Résumé
Background: Irritable Bowel Syndrome (IBS), a disorder of gut-brain interaction, characterized by abdominal pain and altered bowel habits, affects up to 5 million Canadians, impacting quality of life and mental health. Chronic low-grade inflammation and impaired barrier function have been postulated to underlie IBS symptoms, yet the mechanism remains unclear, limiting current treatment strategies. Past and current research almost exclusively focused on the colon, despite strong evidence implicating the role of diet and immune activation in IBS pathogenesis. Emerging data suggest that diet-microbiota-neuroimmune interactions in the SI, drive the low-grade inflammation and gut dysfunction that underlie IBS symptoms.Hypothesis: Diet-microbiota-neuroimmune interactions in the small intestine, trigger chronic low-grade inflammation and gut dysfunction in patients with IBS.Specifically, (1) the density of inflammatory cells is higher and neuroimmune gene expression is altered in IBS patients compared to healthy controls and (2) these abnormalities are more pronounced in the small intestine compared to the colon.Aims: To assess microbial and neuroimmune profiles in the small intestine and colon of IBS patients and healthy controls.Method: 36 IBS patients and 18 healthy controls will be assessed for gastrointestinal symptoms, psychological health, and diet. Biopsies from the SI and colon will undergo conventional and advanced analyses to map immune cell density, neuroimmune interactions, and gene expression. Significance: This project will provide the first comprehensive mapping of neuroimmune profiles along the intestinal tract in IBS patients and healthy individuals, highlighting the small intestine as a critical site of gut dysfunction, where IBS symptoms originate.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529766
Name
Giordano Emma
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Comprehensive characterization of neuroimmune profiles along the gastrointestinal tract of patients with Irritable Bowel Syndrome
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Barrier Function; Diet; Irritable Bowel Syndrome; Microbiota; Neuroimmune System; Visceral Hypersensitivity
Abstract
Background: Irritable Bowel Syndrome (IBS), a disorder of gut-brain interaction, characterized by abdominal pain and altered bowel habits, affects up to 5 million Canadians, impacting quality of life and mental health. Chronic low-grade inflammation and impaired barrier function have been postulated to underlie IBS symptoms, yet the mechanism remains unclear, limiting current treatment strategies. Past and current research almost exclusively focused on the colon, despite strong evidence implicating the role of diet and immune activation in IBS pathogenesis. Emerging data suggest that diet-microbiota-neuroimmune interactions in the SI, drive the low-grade inflammation and gut dysfunction that underlie IBS symptoms.Hypothesis: Diet-microbiota-neuroimmune interactions in the small intestine, trigger chronic low-grade inflammation and gut dysfunction in patients with IBS.Specifically, (1) the density of inflammatory cells is higher and neuroimmune gene expression is altered in IBS patients compared to healthy controls and (2) these abnormalities are more pronounced in the small intestine compared to the colon.Aims: To assess microbial and neuroimmune profiles in the small intestine and colon of IBS patients and healthy controls.Method: 36 IBS patients and 18 healthy controls will be assessed for gastrointestinal symptoms, psychological health, and diet. Biopsies from the SI and colon will undergo conventional and advanced analyses to map immune cell density, neuroimmune interactions, and gene expression. Significance: This project will provide the first comprehensive mapping of neuroimmune profiles along the intestinal tract in IBS patients and healthy individuals, highlighting the small intestine as a critical site of gut dysfunction, where IBS symptoms originate.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Giordano, Emma
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~